Scientists reveal breakthrough blood pressure treatment that works when others fail
SMRTR summary
A groundbreaking treatment called baxdrostat significantly lowers blood pressure in patients resistant to existing medications, reducing levels by 9-10 mmHg more than placebo in clinical trials. The once-daily pill works by blocking aldosterone production, helping 40% of patients reach healthy blood pressure levels compared to less than 20% on placebo—potentially benefiting half a billion people worldwide who struggle with uncontrolled hypertension.
SMRTR provides this summary for quick context. The original article belongs to Science Daily.
Read the original article